SNOA
Sonoma Pharmaceuticals, Inc.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies | Q3 2025 | Q4 2025 | → $3.54 | +16% |
| Citadel Advisors | Q3 2024 | Q4 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Sonoma Pharmaceuticals, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jan 2, 2026 — the most recent Form 4 on file — not from today.
- Form 40001683168-26-000045Jan 2, 2026
- Form 40001683168-26-000042Jan 2, 2026
- Form 40001683168-26-000036Jan 2, 2026
- Form 40001683168-26-000032Jan 2, 2026
- Form 40001683168-26-000031Jan 2, 2026
- Form 40001683168-26-000030Jan 2, 2026
- Form 40001683168-25-004664Jun 20, 2025
- Form 40001683168-25-004663Jun 20, 2025
- Form 40001683168-25-004662Jun 20, 2025
- Form 40001683168-25-004661Jun 20, 2025
- Form 40001683168-25-000084Jan 3, 2025
- Form 40001683168-25-000083Jan 3, 2025
- Form 40001683168-25-000082Jan 3, 2025
- Form 40001683168-25-000081Jan 3, 2025
- Form 40001683168-25-000080Jan 3, 2025
Fundamentals
XBRL · Sonoma Pharmaceuticals, Inc.Annual figures sourced directly from Sonoma Pharmaceuticals, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Sonoma Pharmaceuticals, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14ADEFINITIVE PROXY STATEMENTMay 5, 2026
- 8-KCURRENT REPORTApr 30, 2026
- S-1/AAMENDMENT NO. 1 TO FORM S-1Apr 23, 2026
- S-1FORM S-1Apr 17, 2026
- 8-KCURRENT REPORTApr 9, 2026
- 10-QFORM 10-Q FOR DEC 2025Feb 10, 2026
- 8-KCURRENT REPORTJan 28, 2026
- 8-KFORM 8-KJan 12, 2026
- 8-KCURRENT REPORTJan 2, 2026
- 10-QFORM 10-Q FOR SEP 2025Nov 4, 2025
- 8-KFORM 8-KOct 23, 2025
- 8-KCURRENT REPORTOct 9, 2025
- 8-KCURRENT REPORTSep 29, 2025
- 8-KCURRENT REPORTSep 26, 2025
- 8-KFORM 8-KAug 29, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2025 | Q4 2025 | $3.05 | $3.54 | +16% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.